FDA Rejects Orexo’s Opioid Overdose Drug, Grants Third Indication for Phathom’s Voquezna

By /

In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as BioSpace keeps you up to date on all of the FDA’s decisions in 2024.

Scroll to Top